Belly tissue used to bypass brain barrier in cancer fight
NCT ID NCT04222309
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a new surgical approach for recurrent glioblastoma, an aggressive brain cancer. After standard tumor removal, surgeons place a piece of abdominal tissue (omentum) into the brain cavity to bypass the blood-brain barrier. The study involves 10 adults and primarily checks for safety issues like infection, stroke, or rapid tumor growth over 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
omental free flap (a piece of abdominal tissue transplanted into the brain)
What this could lead to
If successful, this could provide a new way to deliver treatments directly to brain tumors, potentially improving outcomes for recurrent glioblastoma.
What could go wrong
This is a very early phase 1 trial with only 10 participants, focused on safety. The procedure is invasive and carries risks like infection, stroke, or tumor progression. It may not improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lenox Hill Brain Tumor Center
New York, New York, 10075, United States